The largest database of trusted experimental protocols

Anti cd3 mab clone okt3

Manufactured by Novartis

Anti-CD3 mAb (clone OKT3) is a monoclonal antibody that specifically binds to the CD3 complex on the surface of T cells. It is commonly used as a research tool in immunology and cell biology studies.

Automatically generated - may contain errors

3 protocols using anti cd3 mab clone okt3

1

Expansion of Peptide-specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptide-specific CD8+ T cells were expanded using an aAPC as described previously (31 (link), 32 (link), 40 (link)–42 (link)). PBMCs were isolated from healthy volunteers and stimulated with 50 ng/ml anti-CD3 mAb (clone OKT3) in the presence of 100 IU/ml human IL-2 (Novartis) 3 days before transduction. Activated T cells were retrovirally transduced with TCR genes by centrifuging 1 hour at 1,000 g at 32°C. Following transduction, CD8+ T cells were purified and plated at 2 × 106 cells/well in RPMI 1640 supplemented with 10% human AB serum. The stimulator wt-aAPC or mut-aAPC was pulsed with 10 μg/ml A2-restricted wild-type MART127–35 or heteroclitic NY-ESO-1157–165 peptide for 6 hours at room temperature. The aAPC was then irradiated at 200 Gy, washed, and added to the responder T cells at a responder to stimulator ratio of 20:1. Starting the next day, 10 IU/ml IL-2 (Novartis) and 10 ng/ml IL-15 (Peprotech) were added to the cultures every three days. T cells were harvested, counted, and restimulated every week. T cell analysis was performed one day prior to or on the day of restimulation. A2/HIV pol476–484 peptide was used as a control.
+ Open protocol
+ Expand
2

Expansion of Tumor-Specific CD8+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral T cells were stimulated with 50 ng/mL anti-CD3 mAb (clone OKT3) and 100 IU/mL human IL2 (Novartis) for 3 days and retrovirally transduced with TAK1α or β gene fused with ΔNGFR or with ΔNGFR alone (control). CD8+ T cells were purified using the CD8+ T Cell Isolation Kit (Miltenyi Biotec) and subsequently expanded using aAPCs as described previously (38 (link), 39 (link), 41 (link)). Briefly, CD8+ T cells were plated at 2×106 cells/well in RPMI 1640 supplemented with 10% human AB serum. Where indicated, A24-aAPCs was pulsed with 1 μg/ml A24-restricted WT1235–243 peptide (GenWay Biotech) for 6 hrs at room temperature and irradiated at 200 Gy before use. B57-aAPCs were always used without any peptide pulse. Starting the next day, 10 IU/ml IL2 (Novartis) and 10 ng/ml IL15 (Peprotech) were added to the cultures every three days. T cells were harvested, counted, and restimulated every week. T-cell analysis was performed one day prior to or on the day of restimulation.
+ Open protocol
+ Expand
3

Expanding Peptide-Specific T Cells using aAPC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peptide-specific T cells were expanded using an aAPC as described previously23 (link)24 (link). PBMCs were isolated from healthy volunteers and stimulated with 50 ng/ml anti-CD3 mAb (clone OKT3) in the presence of 100 IU/ml human IL-2 (Novartis) 3 days before transduction. Activated T cells were retrovirally transduced with TCR genes by centrifuging 1 hour at 1,000 g at 32 °C. Following transduction, CD4+ or CD8+ T cells were purified using anti-CD4 or anti-CD8 Microbeads (Miltenyi Biotec) and plated at 2 × 106 cells/well in RPMI 1640 supplemented with 10% human AB serum. The stimulator aAPC was pulsed with 10 μg/ml A2-restricted wild-type MART127–35 for 6 hours at room temperature. The aAPC was then irradiated at 200 Gy, washed, and added to the responder T cells at a responder to stimulator ratio of 20:1. Starting the next day, 10 IU/ml IL-2 (Novartis) and 10 ng/ml IL-15 (Peprotech) were added to the cultures every 3 days. T cells were harvested, counted, and restimulated every week. T cell analysis was performed one day prior to or on the day of restimulation.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!